\-\ Texto\\:\\ \ \(0\)\
\-\ unknown\\.\ \(36\)\
\-\ radiographic\\ following\\.\ \(0\)\
\-\ there\\ are\\ multiple\\ areas\\ of\\ pleural\\ thickening\\ and\\ calcified\\ pleural\\ plaques\\,\\ especially\\ on\\ the\\ diaphragmatic\\ surfaces\\.\ \(0\)\
\-\ asbestos\\ pleural\\ disease\ \(0\)\
\-\ atelectasis\ \(143\)\
\-\ pleural\\ metastases\ \(1\)\
\-\ malignant\\ mesothelioma\ \(14\)\
\-\ prior\\ us\\ navy\\,\\ worked\\ in\\ ship\\'s\\ engine\\ rooms\\ with\\ exposure\\ to\\ asbestos\\.\\ \\ follow\\-on\\ career\\ was\\ in\\ shipyards\\ with\\ exposure\\ to\\ asbestos\\ lagging\\.\ \(0\)\
\-\ known\\ history\\ of\\ asbestos\\ exposure\\ is\\ highly\\ suggestive\\ of\\ etiology\\.\\ \\ no\\ associated\\ respiratory\\ symptoms\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ asbestos\\:\\ 0\\.3112342031801287\ \(0\)\
\-\ exposure\\:\\ 0\\.18271522896573192\ \(0\)\
\-\ pleural\\:\\ 0\\.18182740814648196\ \(0\)\
\-\ rooms\\:\\ 0\\.12076052635570544\ \(0\)\
\-\ engine\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ career\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ shipyards\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ lagging\\:\\ 0\\.11126535949871989\ \(0\)\
\-\ follow\\-on\\:\\ 0\\.10571104294929298\ \(0\)\
\-\ ship\\:\\ 0\\.10177019264173434\ \(0\)\
\-\ navy\\:\\ 0\\.09621587609230743\ \(0\)\
\-\ worked\\:\\ 0\\.08042574581917887\ \(0\)\
\-\ surfaces\\:\\ 0\\.07612906693075364\ \(0\)\
\-\ mesothelioma\\:\\ 0\\.07328469207077769\ \(0\)\
\-\ diaphragmatic\\:\\ 0\\.06689990124989277\ \(0\)\
\-\ plaques\\:\\ 0\\.06537626241276641\ \(0\)\
\-\ highly\\:\\ 0\\.05637038435854906\ \(0\)\
\-\ atelectasis\\:\\ 0\\.05624641400896115\ \(0\)\
\-\ calcified\\:\\ 0\\.05024690338565815\ \(0\)\
\-\ metastases\\:\\ 0\\.05001003356223266\ \(0\)\
\-\ suggestive\\:\\ 0\\.05001003356223266\ \(0\)\
\-\ etiology\\:\\ 0\\.0495482382561736\ \(0\)\
\-\ us\\:\\ 0\\.04910150420701248\ \(0\)\
\-\ respiratory\\:\\ 0\\.04859808582059137\ \(0\)\
\-\ especially\\:\\ 0\\.04818083640299262\ \(0\)\
\-\ unknown\\:\\ 0\\.04568328083047269\ \(0\)\
\-\ radiographic\\:\\ 0\\.04442964920258539\ \(0\)\
\-\ malignant\\:\\ 0\\.04231055721067536\ \(0\)\
\-\ thickening\\:\\ 0\\.039679788625936324\ \(0\)\
\-\ areas\\:\\ 0\\.03938831741432968\ \(0\)\
\-\ known\\:\\ 0\\.03704179567758657\ \(0\)\
\-\ following\\:\\ 0\\.03322298297124861\ \(0\)\
\-\ prior\\:\\ 0\\.030056339345237854\ \(0\)\
\-\ symptoms\\:\\ 0\\.029173390094495055\ \(0\)\
\-\ associated\\:\\ 0\\.02762277482065345\ \(0\)\
\-\ \\'s\\:\\ 0\\.02580885778584993\ \(0\)\
\-\ multiple\\:\\ 0\\.024654876759989983\ \(0\)\
\-\ disease\\:\\ 0\\.01913339097555759\ \(0\)\
\-\ there\\:\\ 0\\.017420761047465597\ \(0\)\
\-\ history\\:\\ 0\\.016167322434343608\ \(0\)\
\-\ are\\:\\ 0\\.01595717633602194\ \(0\)\
\-\ was\\:\\ 0\\.013538048249502558\ \(0\)\
\-\ no\\:\\ 0\\.011786906174024683\ \(0\)\
\-\ to\\:\\ 0\\.01170049612172565\ \(0\)\
\-\ in\\:\\ 0\\.011545129592883696\ \(0\)\
\-\ on\\:\\ 0\\.009916315237882577\ \(0\)\
\-\ is\\:\\ 0\\.007702613402530488\ \(0\)\
\-\ \\,\\:\\ 0\\.007416714123761298\ \(0\)\
\-\ of\\:\\ 0\\.004787827430054319\ \(0\)\
\-\ \\.\\:\\ 0\\.003404065105224985\ \(0\)\
\-\ with\\:\\ 0\\.003205593865476431\ \(0\)\
\-\ and\\:\\ 0\\.0024658767908523073\ \(0\)\
\-\ the\\:\\ 0\\.0018938258178578876\ \(0\)\
